Volume | 400,015 |
|
|||||
News | - | ||||||
Day High | 1.36 | Low High |
|||||
Day Low | 1.255 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Personalis Inc | PSNL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.35 | 1.255 | 1.36 | 1.285 | 1.36 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,927 | 400,015 | $ 1.29 | $ 517,699 | - | 0.8906 - 2.43 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 149 | $ 1.28 | USD |
Personalis Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
64.64M | 50.50M | - | 73.48M | -108.3M | -2.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Personalis News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSNL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.35 | 1.40 | 1.255 | 1.34 | 184,294 | -0.065 | -4.81% |
1 Month | 1.41 | 1.67 | 1.255 | 1.40 | 210,550 | -0.125 | -8.87% |
3 Months | 1.44 | 1.85 | 1.18 | 1.42 | 219,857 | -0.155 | -10.76% |
6 Months | 1.51 | 2.38 | 1.12 | 1.58 | 362,312 | -0.225 | -14.90% |
1 Year | 2.06 | 2.43 | 0.8906 | 1.50 | 352,807 | -0.775 | -37.62% |
3 Years | 22.81 | 28.47 | 0.8906 | 6.44 | 421,642 | -21.53 | -94.37% |
5 Years | 23.70 | 53.46 | 0.8906 | 14.57 | 484,093 | -22.42 | -94.58% |
Personalis Description
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. |